β-Carotene: a cancer chemopreventive agent or a co-carcinogen?
- 1 June 2003
- journal article
- review article
- Published by Elsevier in Mutation Research
- Vol. 543 (3), 195-200
- https://doi.org/10.1016/s1383-5742(03)00002-4
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Is Residual Confounding a Reasonable Explanation for the Apparent Protective Effects of Beta-carotene Found in Epidemiologic Studies of Lung Cancer in Smokers?American Journal of Epidemiology, 2002
- Retinoid Signaling and Activator Protein-1 Expression in Ferrets Given -Carotene Supplements and Exposed to Tobacco SmokeJNCI Journal of the National Cancer Institute, 1999
- CHEMOPREVENTION OF LUNG CANCER: The Rise and Demise of Beta-CaroteneAnnual Review of Public Health, 1998
- Stress, hormonal changes, alcohol, food constituents and drugs: factors that advance the incidence of tobacco smoke-related cancer?Trends in Pharmacological Sciences, 1997
- Polymorphism of metabolizing genes and lung cancer histology: prevalence of CYP2E1 in adenocarcinomaCancer Letters, 1997
- Effects of a Combination of Beta Carotene and Vitamin A on Lung Cancer and Cardiovascular DiseaseNew England Journal of Medicine, 1996
- Further mechanisms of non-genotoxic carcinogenesisTrends in Pharmacological Sciences, 1994
- Antimutagenicity profiles of some natural substancesMutation Research, 1992
- Is formation of reactive oxygen by cytochrome P-450 perilous and predictable?Trends in Pharmacological Sciences, 1986
- Relation of Serum Vitamins a and E and Carotenoids to the Risk of CancerNew England Journal of Medicine, 1984